<DOC>
	<DOCNO>NCT01748526</DOCNO>
	<brief_summary>The purpose study ass pharmacokinetics ( ie , body affect drug ) pharmacodynamics ( ie , drug affect body ) 2 different dos canagliflozin ( JNJ-28431754 ) healthy Indian volunteer .</brief_summary>
	<brief_title>A Study Assess Pharmacokinetics Pharmacodynamics Canagliflozin ( JNJ-28431754 ) Healthy Indian Volunteers</brief_title>
	<detailed_description>This study open-label ( volunteer study staff know identity assign treatment ) , randomize ( treatment assign chance ) , single center , single dose , 2-way cross-over study ( volunteer switch one treatment another ) ass pharmacokinetics pharmacodynamics canagliflozin ( drug currently investigate treatment type 2 diabetes mellitus ) healthy Indian volunteer . The study consist 3 phase : single screening phase , baseline phase 2 day per period , open-label treatment phase include 2 treatment period ( Periods 1 2 ) . During Period 1 , volunteer randomly assign receive single dose either 200 mg ( Treatment A ) 300 mg ( Treatment B ) canagliflozin Day 1 . During Period 2 , volunteer receive dose canagliflozin ( Treatment A B ) receive Period 1 . The duration treatment period 4 day treatment period separate 14 day washout period ( medication give ) . Each volunteer participate study approximately 45 day .</detailed_description>
	<mesh_term>Canagliflozin</mesh_term>
	<criteria>Volunteers must body mass index ( BMI = weight kg/height m2 ) 18 35 kg/m2 ( inclusive ) body weight less 50 kg Volunteer must glomerular filtration rate ( volume fluid filter kidney ) equal 90 mL/min/1.73 m2 use Modification Diet Renal Disease calculation Fasting blood glucose screen must less 100 mg/dL 2 hour plasma glucose follow oral glucose tolerance test ( conduct screening ) must less 140 mg/dL History currently active illness consider clinically significant Investigator illness Investigator considers exclude patient study could interfere interpretation study result Female volunteer breastfeed Volunteer history smoking use nicotinecontaining substance within previous 2 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Canagliflozin ( JNJ-28431754 )</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Indian</keyword>
</DOC>